Life Science Investing Gilead Announces Partnership With PEPFAR to Deliver Twice-Yearly Lenacapavir for HIV Prevention for up to Two Million People in Primarily Low- and Lower-Middle-Income Countries
life science investing Gilead Sciences and Arcus Biosciences Expand Partnership to Include Research Programs in Inflammation
life science investing Gilead Strengthens Early Pipeline in Oncology and Inflammation Through the Acquisition of XinThera
life science investing CHMP Adopts Positive Opinion Recommending Hepcludex® for Full Marketing Authorization for the Treatment of Hepatitis Delta Virus
Angkor Resources Completes First Onshore Seismic Program in Cambodia; Vanderbilt Report Publishes Coverage
Troy Minerals Achieves Key Milestone Toward Operational Mining License for Its Tsagaan Zalaa Silica Project, Mongolia
